DA
Dillon & Associates Portfolio holdings
AUM
$737M
1-Year Return
16.41%
This Quarter Return
+18.67%
1 Year Return
+16.41%
3 Year Return
+121.33%
5 Year Return
+190.29%
10 Year Return
+499.62%
AUM
$308M
AUM Growth
+$45.3M
(+17%)
Cap. Flow
+$320K
Cap. Flow
% of AUM
0.1%
Top 10 Holdings %
Top 10 Hldgs %
45.02%
Holding
67
New
2
Increased
23
Reduced
27
Closed
1
Top Buys
| 1 |
NVIDIA
NVDA
|
$1.71M |
| 2 |
Becton Dickinson
BDX
|
$1.29M |
| 3 |
Constellation Brands
STZ
|
$1.28M |
| 4 |
Euronet Worldwide
EEFT
|
$719K |
| 5 |
Salesforce
CRM
|
$635K |
Top Sells
| 1 |
AbbVie
ABBV
|
$4.84M |
| 2 |
Colgate-Palmolive
CL
|
$939K |
| 3 |
Cognizant
CTSH
|
$592K |
| 4 |
CELG
Celgene Corp
CELG
|
$324K |
| 5 |
Bristol-Myers Squibb
BMY
|
$213K |
Sector Composition
| 1 | Technology | 23.18% |
| 2 | Healthcare | 22.79% |
| 3 | Consumer Staples | 9.86% |
| 4 | Financials | 9.83% |
| 5 | Industrials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WBA
51
DELISTED
Walgreens Boots Alliance
WBA
| $577K | 0.19% |
9,157
| – | – |
|
52
Kellanova
K
$27.6B
| $480K | 0.16% |
8,967
| – | – |
|
53
Cisco
CSCO
$269B
| $469K | 0.15% |
8,683
-225
| -3% | -$12.2K |
|
54
Coca-Cola
KO
$294B
| $370K | 0.12% |
7,877
| – | – |
|
55
Eaton
ETN
$136B
| $354K | 0.12% |
4,366
| – | – |
|
56
Amazon
AMZN
$2.51T
| $335K | 0.11% |
3,760
| – | – |
|
57
Exxon Mobil
XOM
$479B
| $321K | 0.1% |
3,967
-629
| -14% | -$50.9K |
|
58
Emerson Electric
EMR
$74.9B
| $276K | 0.09% |
4,057
| – | – |
|
59
Enbridge
ENB
$105B
| $270K | 0.09% |
7,500
-4,375
| -37% | -$158K |
|
60
Merck
MRK
$210B
| $260K | 0.08% |
3,280
| – | – |
|
61
Target
TGT
$42.1B
| $234K | 0.08% |
+2,925
| New | +$234K |
|
62
UnitedHealth
UNH
$281B
| $222K | 0.07% |
900
| – | – |
|
63
ConocoPhillips
COP
$120B
| $206K | 0.07% |
+3,070
| New | +$206K |
|
64
Berkshire Hathaway Class B
BRK.B
$1.09T
| $200K | 0.07% |
997
| – | – |
|
65
Imunon
IMNN
$14.4M
| $45K | 0.01% |
114
+2
| +2% | +$789 |
|
|
GCVRZ
66
DELISTED
Sanofi Contingent Value Rights
GCVRZ
| $5K | ﹤0.01% |
10,260
| – | – |
|
|
67
Bristol-Myers Squibb
BMY
$95B
| – | – |
-4,090
| Closed | -$213K |
|